Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors

Por Dienstmann, R., Rodon, J., Prat, A., Perez-Garcia, J., Adamo, B., Felip, E., Cortes, J., Iafrate, A. J., Nuciforo, P., Tabernero, J.
Publicado no Ann Oncol (2014)

A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies

Por Spreafico, A, Delord, J-P, De Mattos-Arruda, L, Berge, Y, Rodon, J, Cottura, E, Bedard, P L, Akimov, M, Lu, H, Pain, S, Kaag, A, Siu, L L, Cortes, J
Publicado no Br J Cancer (2015)

Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial

Por Rodon, J., Soria, J. C., Berger, R., Batist, G., Tsimberidou, A., Bresson, C., Lee, J. J., Rubin, E., Onn, A., Schilsky, R. L., Miller, W. H., Eggermont, A. M., Mendelsohn, J., Lazar, V., Kurzrock, R.
Publicado no Ann Oncol (2015)

OS2.2 Highly personalized peptide vaccination for patients with newly diagnosed glioblastoma: the GAPVAC trial

Por Dietrich, P, Wick, W, Hilf, N, Frenzel, K, Gouttefangeas, C, Platten, M, thor Straten, P, Lassen, U, Rodon, J, Bukur, V, Admon, A, van der Burg, S H, von Deimling, A, Kroep, J R, Martinez-Ricarte, F, Okada, H, Ottensmeier, C H, Ponsati, B, Poulsen, H S, Stevanovic, S, Tabatabai, G, Rammensee, H, Sahin, U, Singh-Jasuja, H
Publicado no Neuro Oncol (2018)